Evoking neuronal activity to improve the lives of Alzheimer’s patients
illustration of head wearing vr headset
Spectris, our investigational non-invasive, neuroprotective therapy platform, is designed to evoke specific brain wave activity with the potential to preserve brain structure, cognition, and function among patients living with neurodegenerative disease, including Alzheimer’s disease.
illustration of head wearing vr headset
Our intervention evokes specific brain wave activity with the potential to preserve brain volume, cognition, and function among patients living with Alzheimer’s disease. 
cognito vr headset
Spectris
We are leading a novel category of non-invasive neuroprotective therapy in Alzheimer’s disease with Spectris
cognito vr headset
Watch Video
Cognito's headset design concept
illustration of head wearing vr headset sideview
Why do the brain's electrical activities matter?
Neurons communicate through electric signals, creating rhythmic brain activity known as "brain waves." When groups of neurons start firing at the same time, distinct brain waves form at various ranges. One such range is gamma waves, which play an important role in learning and memory. In Alzheimer’s patients, gamma waves are altered, indicating impairment in normal brain function.1
illustration of head wearing vr headset
How does our treatment work?
Spectris AD is designed to evoke gamma wave activity through non-invasive visual and auditory stimulation. In our OVERTURE feasibility study, it demonstrated slowing of cognitive and functional decline and preservation of brain volume among treated Alzheimer's patients.
Woman using the cognito VR headset
cognito vr headset
Cognito's headset design concept
a woman knitting
a woman drawing
a man petting his doga woman smiling
Exploring treatment across multiple neurodegenerative diseases
Exploring treatment across multiple neurodegenerative diseases
Spectris AD received FDA Breakthrough Device Designation for the treatment of cognitive and functional symptoms associated with Alzheimer’s disease, and we are expanding our approach to many other indications.
Click to enlarge
It all started with a breakthrough from leading MIT neuroscientists
Press, publications & announcements
October 3, 2025
DeviceTalks Podcast with Christian Howell
October 1, 2025
BrightFocus Webinar: Update on Spectris & the HOPE Study
August 22, 2025
Vanguards of Health Care: Cognito’s Gamma Waves Activate Brain
August 14, 2025
Interview: Nasdaq MarketSite with Cognito
August 9, 2025
Interview: Cognito Aims to Preserve Memory in Alzheimer’s Patients
October 3, 2025
DeviceTalks Podcast with Christian Howell
October 1, 2025
BrightFocus Webinar: Update on Spectris & the HOPE Study
August 22, 2025
Vanguards of Health Care: Cognito’s Gamma Waves Activate Brain
August 14, 2025
Interview: Nasdaq MarketSite with Cognito
August 9, 2025
Interview: Cognito Aims to Preserve Memory in Alzheimer’s Patients
Citations

1Traikapi A and Konstantinou N (2021) Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role. Front. Syst. Neurosci. 15:782399. doi: 10.3389/fnsys.2021.782399